Oncotelic Therapeutics, Inc.
USD0.04
+0.00 (+1.53%)
CEO
Vuong Trieu
IPO Date
1993-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.04
Prev. Close
$0.04
Day Low
$0.04
Day High
$0.05
52W Low
$0.02
52W High
$0.11
Market Cap
$0.02B
Volume
0.01M
| 75,000 |
| $0.04 |
| 24 Jun 2026 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | P-Purchase | Acquired | 65,000 | $0.04 |
| 22 Jun 2026 | Shah Amit B. | CFO | P-Purchase | Acquired | 20,000 | $0.05 |
| 17 Jun 2026 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | P-Purchase | Acquired | 239,759 | $0.04 |
| 17 Jun 2026 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | P-Purchase | Acquired | 96,000 | $0.04 |
| 26 Jan 2026 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | A-Award | Acquired | 4,426 | $0.00 |
| 19 Nov 2025 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | A-Award | Acquired | 4,065 | $0.00 |
| 10 Jul 2025 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | P-Purchase | Acquired | 104,000 | $0.01 |
| 10 Jul 2025 | Trieu Vuong | director, 10 percent owner, officer: CHAIRMAN AND CEO | P-Purchase | Acquired | 1 | $0.01 |